Literature DB >> 19674980

Toll-like receptor 7 (TLR7) modulates anti-nucleosomal autoantibody isotype and renal complement deposition in mice exposed to syngeneic late apoptotic cells.

Zi-jian Pan1, Shannon Maier, Karen Schwarz, Jennifer Azbill, Shizuo Akira, Satoshi Uematsu, A Darise Farris.   

Abstract

OBJECTIVES: The objectives of this study were to determine whether late apoptotic cell material directly induces autoantibodies characteristic of systemic lupus erythematosus (SLE) and to investigate the innate recognition pathways involved.
METHODS: B6, B6.MyD88(-/-), B6.TLR7(-/-) and B6.TLR9(-/-) mice were subcutaneously injected with B6 syngeneic late apoptotic thymocytes (SLATs) without adjuvant on days 0, 10, 24 and 37. Sera were tested for IgG antibodies to histones and double-stranded DNA (dsDNA) by ELISA and Crithidia luciliae indirect immunofluorescence. IgG and C3 deposition in kidney glomeruli was assessed by immunostaining and fluorescence microscopy.
RESULTS: SLAT injections induced anti-dsDNA and anti-histone antibodies of the IgG1 and IgG2b isotypes in B6 but not MyD88(-/-) mice. TLR7(-/-) and TLR9(-/-) mice injected with SLATs produced delayed or slightly more robust responses, respectively. SLAT injections induced IgG deposits in renal glomeruli of B6, TLR7(-/-) and TLR9(-/-) mice that were absent in MyD88(-/-) mice. Unlike B6 and TLR9(-/-) animals, TLR7(-/-) mice failed to exhibit IgG colocalised glomerular C3 deposits and demonstrated autoantibodies of primarily the IgG2a isotype.
CONCLUSIONS: Late apoptotic cell-induced anti-histone and anti-dsDNA antibodies require MyD88 but not Toll-like receptor (TLR)9. Moreover, TLR7 promotes glomerular C3 deposition, possibly through a mechanism of altered antibody isotype switching.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19674980      PMCID: PMC2936817          DOI: 10.1136/ard.2009.108282

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  How dying cells alert the immune system to danger.

Authors:  Hajime Kono; Kenneth L Rock
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

Review 3.  Recognition and phagocytosis of cells undergoing apoptosis.

Authors:  J Savill
Journal:  Br Med Bull       Date:  1997       Impact factor: 4.291

4.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.

Authors:  M Botto; C Dell'Agnola; A E Bygrave; E M Thompson; H T Cook; F Petry; M Loos; P P Pandolfi; M J Walport
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

5.  Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.

Authors:  Z Amoura; J C Piette; H Chabre; P Cacoub; T Papo; B Wechsler; J F Bach; S Koutouzov
Journal:  Arthritis Rheum       Date:  1997-12

6.  Selective accumulation of anti-histone antibodies in glomeruli of lupus-prone lpr mice.

Authors:  S Minota; T Yoshio; M Iwamoto; A Takeda; J Masuyama; A Mimori; A Yamada; S Kano
Journal:  Clin Immunol Immunopathol       Date:  1996-07

7.  An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE).

Authors:  C T Ravirajan; C E Sarraf; T V Anilkumar; M C Golding; M R Alison; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

8.  Circulating DNA in systemic lupus erythematosus. Isolation and characterization.

Authors:  C R Steinman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.

Authors:  C Kramers; M N Hylkema; M C van Bruggen; R van de Lagemaat; H B Dijkman; K J Assmann; R J Smeenk; J H Berden
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 10.  Autoantibodies in the diagnosis of systemic rheumatic diseases.

Authors:  C A von Mühlen; E M Tan
Journal:  Semin Arthritis Rheum       Date:  1995-04       Impact factor: 5.532

View more
  11 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.

Authors:  Ying-Yu Wu; Ina Georg; Alejandro Díaz-Barreiro; Nieves Varela; Bernard Lauwerys; Ramesh Kumar; Harini Bagavant; Mireia Castillo-Martín; Fadi El Salem; Concepción Marañón; Marta E Alarcón-Riquelme
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

3.  B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers.

Authors:  Chetna Soni; Eric B Wong; Phillip P Domeier; Tahsin N Khan; Takashi Satoh; Shizuo Akira; Ziaur S M Rahman
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

Review 4.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.

Authors:  T Layer; A Steele; J A Goeken; S Fleenor; P Lenert
Journal:  Clin Exp Immunol       Date:  2011-01-14       Impact factor: 4.330

Review 6.  Toll-like receptors in systemic lupus erythematosus: potential targets for therapeutic intervention.

Authors:  Christopher G Horton; A Darise Farris
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

7.  Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding.

Authors:  Robert F Ashman; J Adam Goeken; Eicke Latz; Petar Lenert
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

Review 8.  Targeting Toll-like receptors for treatment of SLE.

Authors:  Christopher G Horton; Zi-jian Pan; A Darise Farris
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

9.  Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE).

Authors:  Wei Jiang; Gary Gilkeson
Journal:  J Immunother Appl       Date:  2014-03-07

10.  BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation.

Authors:  Ying-Yu Wu; Ramesh Kumar; Ryuji Iida; Harini Bagavant; Marta E Alarcón-Riquelme
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.